Navigation Links
Smog in Warm Weather may Contribute to Stroke Risks in Elderly: Study

Finnish scientists have come up with a study they believe to be the first to evaluate the contribution of fine particle pollution to stroke risks in the elderly.//

Fine particle pollution is made up of tiny particles of dust and soot, less than 2.5 microns, about 1/30th the width of a human hair. They mostly come from car exhaust, power plant emissions and burning of fossil fuels. Ultra-fine particles are less than 0.1 microns and are usually found in car exhaust.

Dr. Jaana Kettunen, from the National Public Health Institute in Kuopio, and colleagues compared air pollution levels from 1998 to 2004 with the number of stroke deaths among elderly subjects above 65 years, living in Helsinki.

A total of 1,304 stroke deaths in the warm season and 1,961 in the cold season were recorded during the study period.

When outdoor levels of fine particle pollution were high, fatal stroke risk rose; but only during Helsinki's warm season, it was seen.

Results were published in the journal Stroke.

During the warm season, every 6 microgram per cubic meter increase in current-day levels of fine particulate air pollution was associated with a 6.9 percent increase in deaths from stroke.

The corresponding stroke death rate for previous-day fine particulate increases was 7.4 percent. However, particulate air pollution had no effect on stroke during the cold season.

Previous-day levels of ultra fine particles plus carbon monoxide were also linked to stroke mortality.

Yet, Kettunen says that "these associations were less robust" than those seen with fine particulate pollution.

"Coarse particles were not statistically significantly associated with stroke deaths." she adds.

"Our results suggest that the levels of combustion-
originating particles rather than coarse particles explain the association between particulate matter and stroke.

“Thus, regulatory efforts shoul
'"/>




Page: 1 2

Related medicine news :

1. Weather Found To Play An Important Role In Cholesterol Levels
2. Breast-fed Children Weather Digestive Disease
3. Delhi Faces Flu Threat Due To Change In Weather
4. Ticks like Sunny Weather
5. Cold Weather deaths on the rise
6. Experts Use Weather to Predict Disease
7. Weather Forecasts Spring Pollen Allergy Severity
8. Railway Station Contributes to Create Awareness on AIDS
9. Fruits And Vegetables Contribute To Memory
10. Record Number of Countries Contributed to UNFPA in 2005
11. Blood Transfusion May Have Contributed Towards Hepatitis C
Post Your Comments:
(Date:9/4/2008)... may be shortchanging their golden years by tappin...iversity of Illinois expert who has studied the fe..., More than three of every four Americans trim th...iming benefits early, a choice many might forego i... consequences, law professor Richard L. Kaplan say...
(Date:9/4/2008)...ncology contract research organization, has publis...uanced Approach to Get Into the Clinic Faster.&quo...al research scientist with 35 years of experience,...mmonly viewed as straightforward investigations ru...rue integration with preclinical, regulatory and c...
(Date:9/4/2008)...NORWICH, England and ONGAR, Ireland,Sept. 4 /PRNe...ofield Media,Europe Ltd, announced on the 29th Aug... publication from Silverdog Publishing., Health a... the iconic,Health and Safety at Work Act 1974 and.... It has been relied upon by blue-chip corporates,...
(Date:9/4/2008)...-FirstCall/ -- ULURU Inc. (Amex:,ULU) today announ...Weisel,Partners Healthcare Conference at 3:15 p.m....out ULURU Inc.:, ULURU Inc. is an emerging specia...ent of a portfolio of wound management, plastic su...nd consumers improved clinical,outcomes through co...
Breaking Medicine News(10 mins):Health News:New guide explores making the most of Social Security 2Health News:New guide explores making the most of Social Security 3Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 2Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 3Health News:Schofield Publishing Enters the Newsletter Market 2
...zart, could have a therapeutic effect on epilepsy,...448 have been found to decrease epileptic attacks....national research on music therapy, said it was ve...ns could also trigger the "Mozart Effect." Patient...
...at Kansas State University have published the firs...educed by another compound in the egg, the lecith...Jiang and Sang K. Noh. A peer-reviewed research pa...choline decreses the lymphatic absorption of chole...
...(MSI), the sole franchisee for US based Medicine S...vi Mumbai, Baroda and Pune, has dropped Chennai fr...y. According to informed sources, MSI, which recen...ions from the present 19 outlets to 50 by the end ...
... levels may depend not only on what he or she eats...iddle-aged and older adults who ate frequently thr...vels compared with those who tended to down one or...act that the frequent eaters, on average, had a hi...
Other Medicine News:Health News:Lecithin lowers cholesterol absorption in body 2
(Date:9/3/2008)...alysis showed that Multaq(R) (dronedarone) decreas...l fibrillation or atrial flutter already ... BRIDGEWATER, N.J., Sept. 3 /PRNewswire-FirstCall/... from the ATHENA study were presented today at,the...iety of Cardiology,congress 2008, in Munich, Germa...
(Date:9/3/2008)...09 to be Evaluated in Repeat-Dosing Study in Subje...re-FirstCall/ -- Sangamo,BioSciences, Inc. (Nasdaq...se,2 clinical trial (SB-509-801) to evaluate its d...degenerative motor-neuron disease for which there,...mo,s drug, SB-509, is an injectable formulation of...
(Date:9/2/2008)...elegates Join World Vision, ONE to Build Hope and ...swire/ -- Delegates to the,Republican Party Conven...communities around the world including evacuees in...V and AIDS in developing countries: "We are here,t...nviting party delegates to do,something unconventi...
(Date:9/2/2008)...t of three ongoing randomized chemotherapy combina...atment of specific cancers -, ROCKVILLE, Md., Sep...es, Inc. (Nasdaq: HGSI ) today reported initial t...clinical trial of its TRAIL receptor antibody,HGS-...(Velcade) in patients,with advanced multiple myelo...
Breaking Medicine Technology:Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 2Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 3Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 4Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 5Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 2Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 3Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 4Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 5Senator Frist and Convention Delegates Support AIDS-Affected People Around the World, Raise Funds for Gustav Evacuees 2Senator Frist and Convention Delegates Support AIDS-Affected People Around the World, Raise Funds for Gustav Evacuees 3Senator Frist and Convention Delegates Support AIDS-Affected People Around the World, Raise Funds for Gustav Evacuees 4Human Genome Sciences Reports Initial Results of Randomized Phase 2 Trial of HGS-ETR1 in Combination With Bortezomib in Advanced Multiple Myeloma 2Human Genome Sciences Reports Initial Results of Randomized Phase 2 Trial of HGS-ETR1 in Combination With Bortezomib in Advanced Multiple Myeloma 3Human Genome Sciences Reports Initial Results of Randomized Phase 2 Trial of HGS-ETR1 in Combination With Bortezomib in Advanced Multiple Myeloma 4Human Genome Sciences Reports Initial Results of Randomized Phase 2 Trial of HGS-ETR1 in Combination With Bortezomib in Advanced Multiple Myeloma 5Human Genome Sciences Reports Initial Results of Randomized Phase 2 Trial of HGS-ETR1 in Combination With Bortezomib in Advanced Multiple Myeloma 6AWWA Urges Science Based Approach in Addressing Pharmaceutical Compounds in Water 16924 1AWWA Urges Science Based Approach in Addressing Pharmaceutical Compounds in Water 16924 2AWWA Urges Science Based Approach in Addressing Pharmaceutical Compounds in Water 16924 3Antioxidant users dont live longer analysis of studies concludes 2904 1Antioxidant users dont live longer analysis of studies concludes 2904 2Antioxidant users dont live longer analysis of studies concludes 2904 3Hereditary breast cancer a high cost to patient and health care provider alike 16918 1Hereditary breast cancer a high cost to patient and health care provider alike 16918 2Hereditary breast cancer a high cost to patient and health care provider alike 16918 3Senetek PLC Reports 2007 Financial Results 16915 1Senetek PLC Reports 2007 Financial Results 16915 2Senetek PLC Reports 2007 Financial Results 16915 3
...07. Giaconda Ltd (ASX: GIA) today,announced that t...ved the Company,s Investigational New Drug applica...aR to treat patients with,Crohn,s Disease infected...P). , ,The Company understands that its lead produ...d to the FDA for this indication. There,are no ant...
..., 2007 /PRNewswire-FirstCall/ --,Allos Therapeutic...,European Communities, with a favorable opinion of...e European Medicines Agency (EMEA),has granted or...olate PDX (pralatrexate) for the treatment of pati...ly 2006, the U.S. Food and,Drug Administration (FD...
Other Medicine Technology:FDA approves MyocondaR IND for MAP in Crohn's Disease 2FDA approves MyocondaR IND for MAP in Crohn's Disease 3FDA approves MyocondaR IND for MAP in Crohn's Disease 4Allos Therapeutics' PDX Granted Orphan Medicinal Product,Designation by the European Commission 2Allos Therapeutics' PDX Granted Orphan Medicinal Product,Designation by the European Commission 3Allos Therapeutics' PDX Granted Orphan Medicinal Product,Designation by the European Commission 4
...iCharts, is a state-of-the-art electronic medical ...8. It is a proven, comprehensive electronic medica...are providers at the point of care and to be share...nternet. AmkaiCharts chronicles patient history, e...
...fice seamlessly integrates practice management and...nd clinical workflow. Instantly access registratio...eporting information for multiple practices, provi...tely improves productivity by simplifying office w...
The ReSeeVit Slit Lamp System is an easy-to-use digital video imaging system that captures anterior segment and retinal images for documentation, diagnosis and patient education. The package includes
...e is an important movement in our country to provi...ns. In fact, recent government regulations require...s device affords your wheelchair-bound patients ea...t without having to leave their wheelchair. , ,The...
Medicine Products: